This content is from: Portfolio New Valuation Data Show Private Companies Weathering the Downturn Better Than Public Peers Good and bad companies are being treated the same right now. Being able to discern between the two is where the opportunities are, says EQUIAM’s Ziad Makkawi. By Hannah Zhang May 19, 2022
This content is from: Premium Hedge Funds Are Holding Their Breath on This Biopharma IPO Several prominent hedge funds disclosed sizable stakes in PepGen, which went public earlier this month. By Stephen Taub May 23, 2022
This content is from: Portfolio Bill Ackman Gets Pummeled in April Pershing Square’s big Netflix loss was only part of Ackman’s problems, as the NYSE pulled plans to list warrants for his proposed SPARC. By Michelle Celarier May 03, 2022
This content is from: Premium Newly Public Companies Show Some Life Many recent IPOs have rebounded sharply from their lows but still remain well below the prices at which they went public. By Stephen Taub March 29, 2022
This content is from: Portfolio Why Investors Should Say No to Tech IPOs In the last decade, late-stage investments made before companies go public have generated the highest alpha. By Hannah Zhang May 10, 2022
This content is from: Premium Viking Global Hits Rough Seas The firm’s star hybrid fund is the latest public-private portfolio to report a sharp loss in the first quarter. By Stephen Taub April 28, 2022
